Vaccines against Lassa virus disease – Joint EDCTP and CEPI call

Nov 21, 2019

The joint EDCTP and CEPI call on “Vaccines against Lassa virus disease” was launched to support distinct strategic actions (clinical research activities) which are part of efforts to prepare and conduct a large-scale clinical trial. The goal is to achieve proof of concept and/or demonstrate the efficacy of novel candidate vaccines against Lassa virus (LASV).

Members

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Toujours activé

Functional

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Type	Durée	Description
GPS	1	29 minutes	This cookie is set by Youtube and registers a unique ID for tracking users based on their geographical location

News

Vaccines against Lassa virus disease – Joint EDCTP and CEPI call

Members

Our adress

Extra links

Newsletters